- Headquarters
- Shanghai
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- alphabiopharma.com
- Total Funding
- $73.0M
- Last Round
- $8.0M Series BApr 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
Alpha Biopharma focuses on innovative drugs, spanning clinical development through commercialization. Its team integrates medical, clinical operations, regulatory, and commercialization capabilities. The company establishes strategic partnerships with international pharmaceutical companies and research institutes to support its work in innovative drug development.
Summary
It lists 11–50 employees. It has raised $73.0M in total across 2 rounds, most recently a $8.0M Series B round in Apr 2022. Investors include Qiming VP, TF Capital and LYZZ Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2022
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Novel bicyclic peptides and drug conjugates for cancer
China's leading blood products manufacturer
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/alpha-biopharma"><img src="https://indexed.vc/api/badge/company/alpha-biopharma" alt="Alpha Biopharma on Indexed.vc" width="260" height="76" /></a>